About
ASX-listed biotechs continue to make a mark globally, but are often put in the ‘too hard basket’ by investors. This half day virtual event aims to change that. ausbiz, in partnership with the ASX, invites you to attend "Biotech Unlocked: Showcasing Australia's Next Investment Horizon" on Thursday, November 4th from 9.00am.

Experts will explain why biotechs are worthy investments; there will also be a 'valuation masterclass' to help you better understand how and why biotechs are valued as they are, and how to ascribe value in the future.

This event will also showcase some of the most exciting ASX-listed biotech companies, featuring in-depth conversations with the CEOs to uncover how they will capitalise on milestones to unlock future returns.
When
Thu, Nov 4, 2021 · 9:00 AM Sydney (GMT 11:00)
Agenda
  • 9.00:
  • 9.10: The Investment Thesis.
  • 9.35: Biotech showcase ONE (plus Q&A)
  • 9.55: Lightning round one - meet the CEO's of two biotech small caps
  • 10.00: Biotech showcase TWO (plus Q&A)
  • 10.20: Lightning round two - meet the CEO's of two biotech small caps
  • 10.25: Biotech showcase THREE (plus Q&A)
  • 10.45: Lightning round three - meet the CEO's of two biotech small caps
  • 10.50: Biotech showcase FOUR (plus Q&A)
  • 11.10 Biotech showcase FIVE (plus Q&A)
  • 11.30: Valuation Masterclass. Whiteboard session - a fund manager talks through a biotech they hold and how they performed the valuation.
  • 12.00: Close
Presenters
1633900813-535284fd6d5cb212
Elyse Shapiro
Healthcare Analyst, Cannacord Genuity
1633901076-f5be2eb4496c525e
Hashan De Silva
Head of Healthcare Research, Karst Peak Capital
1634694522-e1117aa66c97a4fd
Matt McNamara
Chief Investment Officer, Horizon 3 Biotech
1633901271-a4098aff2c6205f4
Chris Kallos
Director and Life Science Analyst, MST Access
1632365234-588b1c8d3a474d30
Dr. Christian Behrenbruch
CEO & Managing Director, Telix
1632365320-0842ac11ea8d12a4
Dr. Megan Baldwin
CEO & Managing Director, Opthea
1633493682-d345676a5a34cbb6
Marc Voigt
CEO, Immutep
1632365438-64735961dcf8f40d
Leslie Chong
CEO & Managing Director, Imugene
1633493596-c88732a10082d57c
Ralph Highnam
CEO & Managing Director, Volpara